scispace - formally typeset
S

Susanne Buder

Researcher at Robert Koch Institute

Publications -  31
Citations -  417

Susanne Buder is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Gonorrhea & Antibiotic resistance. The author has an hindex of 7, co-authored 27 publications receiving 244 citations.

Papers
More filters
Journal ArticleDOI

Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.

TL;DR: This work provides the first use of joint analysis of WGS and epidemiological data in an international programme for regional surveillance of sexually transmitted infections and provides a framework for genomic surveillance of gonococci through standardised sampling, use of W GS, and a shared information architecture for interpretation and dissemination.
Journal ArticleDOI

The Laboratory Diagnosis of Neisseria gonorrhoeae: Current Testing and Future Demands.

TL;DR: New developments of molecular techniques and microfluidic systems represent promising opportunities to design point-of-care tests for rapid detection of Ng with high sensitivity and specificity, and there is reason to hope that such tests may also provide antimicrobial resistance data in the future.
Journal ArticleDOI

Bacterial sexually transmitted infections.

TL;DR: In recent years, Neisseria (N.) gonorrhoeae has shown a significant development of resistance, with high‐level monoresistance and multiresistance to antibiotics commonly used for treatment, so it is imperative that sensitivity testing of N. gonor rhoeae be performed in addition to nucleic acid amplification tests (NAATs).
Journal ArticleDOI

Sexuell übertragbare Infektionen in Deutschland

TL;DR: In this paper, the authors provided an overview over STIs in Germany and estimated 3900 new HIV diagnoses in 2015, 57% of newly diagnosed infections were attributed to men who have sex with men (MSM).
Journal ArticleDOI

Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.

TL;DR: The rates of ciprofloxacin resistance and penicillin resistance were very high across Germany, and the percentage of isolates with resistance to cefixime was low, whereas azithromycin resistance showed high levels during the observation period.